- This meeting has passed.
ANCO’s Hematologic Malignancies Update 2022
November 12, 2022 @ 8:00 am - 12:30 pm
The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses.
The program takes place in San Francisco on November 12th
Registration and continental breakfast will be available at 8:00 am; presentations begin at 9 am. The program will conclude by 12:30pm.
ANCO acknowledges the support of Adaptive Biotechnologies, ADC Therapeutics, Amgen, Beigene, Incyte Corporation, Kite Pharma, Merck, Sanofi Aventis, SeaGen, and Secura Bio in making this program possible.
Attendance is limited to the first 50 health care professionals per location.
“Being part of a multi-site private practice, we have a lot going on and I rely on ANCO for its fantastic education, CME opportunities and access to local experts at speaking engagements. ANCO also looks out for our best interests with its advocacy efforts and practice management tools. I look to them as a go-to local resource. There’s no question that ANCO membership is a great value for all it provides. I’m proud to be on the board and part of this thriving organization.”
Zachary Koontz, MD
Pacific Cancer Care